Modular cytosine base editing promotes epigenomic and genomic modifications

Modular cytosine base editing promotes epigenomic and genomic modifications

Modular cytosine base editing promotes epigenomic and genomic modifications

Nucleic acids research vol. 52,2 (2024): e8. doi:10.1093/nar/gkad1118

Nucleic acids research vol. 52,2 (2024): e8. doi:10.1093/nar/gkad1118

Nucleic acids research vol. 52,2 (2024): e8. doi:10.1093/nar/gkad1118

Weischedel, Julian et al.

Weischedel, Julian et al.

Weischedel, Julian et al.

Prokaryotic and eukaryotic adaptive immunity differ considerably. Yet, their fundamental mechanisms of gene editing via Cas9 and activation-induced deaminase (AID), respectively, can be conveniently complimentary. Cas9 is an RNA targeted dual nuclease expressed in several bacterial species. AID is a cytosine deaminase expressed in germinal centre B cells to mediate genomic antibody diversification. AID can also mediate epigenomic reprogramming via active DNA demethylation. It is known that sequence motifs, nucleic acid structures, and associated co-factors affect AID activity. But despite repeated attempts, deciphering AID’s intrinsic catalytic activities and harnessing its targeted recruitment to DNA is still intractable. Even recent cytosine base editors are unable to fully recapitulate AID’s genomic and epigenomic editing properties. Here, we describe the first instance of a modular AID-based editor that recapitulates the full spectrum of genomic and epigenomic editing activity. Our ‘Swiss army knife’ toolbox will help better understand AID biology per se as well as improve targeted genomic and epigenomic editing.

Winterthurerstrasse 190
Irchel Y23K74
Zürich 8057
Switzerland

EVIIVE is a registered entity in Zürich, Switzerland. All scientific content, claims, or technologies referenced on this site are for informational purposes only and are subject to ongoing research, regulatory evaluation, and change. This site does not provide medical advice or substitute professional consultation.

Winterthurerstrasse 190
Irchel Y23K74
Zürich 8057
Switzerland

EVIIVE is a registered entity in Zürich, Switzerland. All scientific content, claims, or technologies referenced on this site are for informational purposes only and are subject to ongoing research, regulatory evaluation, and change. This site does not provide medical advice or substitute professional consultation.

Winterthurerstrasse 190
Irchel Y23K74
Zürich 8057
Switzerland

EVIIVE is a registered entity in Zürich, Switzerland. All scientific content, claims, or technologies referenced on this site are for informational purposes only and are subject to ongoing research, regulatory evaluation, and change. This site does not provide medical advice or substitute professional consultation.